Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafluprost Switch Study in Glaucoma/OH
NCT01369771Phase 4Completed
- Sponsor
- FinnMedi
- Start
- Aug 2010
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tafluprost in ocular hypertension, open-angle glaucoma (OAG), sponsored by FinnMedi. Started Aug 2010; status: completed.
02
Drugs
tafluprost
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT01369771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01369771.